Agenus INC Form 4 insider transactions

Agenus Inc. CEO Garo Armen received 3,530 shares of common stock at $4.62 per share in lieu of cash salary for the pay period ending October 18, 2024, while also reporting other transactions and holdings.

Agenus Inc. CEO Garo H. Armen received 3,349 shares of common stock at $4.87 per share in lieu of cash salary for the pay period ending October 4, 2024, according to a Form 4 filing.

Director Ulf Wiinberg reports acquiring 3,423.478 Deferred Stock Units of Agenus Inc. under the company's Amended and Restated Directors' Deferred Compensation Plan.

Director Timothy Wright acquired deferred stock units in Agenus Inc. under the company's Amended and Restated Directors' Deferred Compensation Plan.

Director Susan B. Hirsch acquired 3,172.98 deferred stock units of Agenus Inc. on October 1, 2024, under the company's Amended and Restated Directors' Deferred Compensation Plan.

Agenus Inc. CEO Garo Armen received 2,793 shares of common stock at $5.84 per share as payment for his salary for the pay period ending September 20, 2024.

Garo Armen, Chairman and CEO of Agenus Inc., received 3,295 shares of common stock in lieu of cash salary for the pay period ending September 6, 2024, at a price of $4.95 per share.

Agenus Inc. CEO Garo Armen received 2,982 shares of common stock as payment for his salary for the pay period ending August 23, 2024, while also disposing of 85,333 shares.

Agenus Inc. CEO Garo Armen received 3,204 shares of common stock as payment for his salary for the pay period ending August 9, 2024, and disposed of 82,351 shares.

Director Thomas L. Harrison reports the acquisition of 7,500 stock options in Agenus Inc. on August 7, 2024.

Agenus Inc. CEO Garo Armen received 2,486 shares of common stock in lieu of cash salary for the pay period ending July 26, 2024, at a price of $6.56 per share.

Agenus Inc. CEO Garo H. Armen received 1,046 shares of common stock as payment for his salary for the pay period ending July 12, 2024, while also disposing of 76,661 shares.

Agenus Inc. CEO Garo H. Armen received 973 shares of common stock as part of his salary in lieu of cash, according to a recent SEC Form 4 filing.

Director Timothy Wright reported acquiring deferred stock units in Agenus Inc. under the company's Amended and Restated Directors' Deferred Compensation Plan.

Director Ulf Wiinberg reports acquisition of deferred stock units under Agenus Inc.'s Amended and Restated Directors' Deferred Compensation Plan.

Director Susan B. Hirsch reports acquiring deferred stock units in Agenus Inc. under the company's Amended and Restated Directors' Deferred Compensation Plan.

Agenus Inc.'s Chief Medical Officer, Steven O'Day, reports the grant of stock options following shareholder approval at the company's annual meeting.

Christine Klaskin, PFO & PAO of Agenus Inc., reports the acquisition of stock options following shareholder approval at the company's annual meeting.

Director Timothy Wright reports the acquisition of stock options in Agenus Inc. following shareholder approval.

Director Brian Corvese reports the acquisition of stock options in Agenus Inc. following shareholder approval.

A Form 4 filing reveals Agenus Inc. CEO Garo H. Armen received stock in lieu of cash salary and exercised stock options.

Agenus Inc. CEO Garo H. Armen received 1,040 shares of common stock in lieu of cash salary for the pay period ending May 31, 2024, as part of an approved compensation arrangement.

A Form 4 filing reveals Agenus Inc. CEO Garo Armen received stock in lieu of cash salary, with additional transactions involving shares held in IRA accounts and through a general partnership.

Agenus Inc. CEO Garo Armen received 1,248 shares of common stock as payment for his salary for the pay period ending May 3, 2024, as part of an arrangement approved by the company's Compensation Committee.

Director Ulf Wiinberg acquired 5,000 stock options in Agenus Inc. on February 5, 2024, according to a Form 4 filing.

Director Susan B. Hirsch reports the acquisition of stock options in Agenus Inc. on February 5, 2024.

Director Brian Corvese reports the acquisition of stock options in Agenus Inc. on February 5, 2024.

Director Allison Jeynes-Ellis received 5,000 stock options from Agenus Inc. on February 5, 2024, which will vest on February 5, 2025.

Director Timothy Wright received 7,500 stock options in Agenus Inc. on February 5, 2024, vesting on February 5, 2025.

Agenus Inc. CEO Garo H. Armen received 3,080 shares of common stock in lieu of cash salary for the pay period ending April 19, 2024, while also disposing of 69,797 shares.